Spectrum of Pathological Lesions Observed in Post-Transplant Gastrointestinal Mucosal Biopsies
DOI:
https://doi.org/10.21276/apalm.3327Keywords:
solid organ transplantation, colitis, transplant recipients, gastrointestinal tract, kidney transplantation, cytomegalovirusAbstract
Background: Gastrointestinal mucosal biopsies in post-transplant patients reveal diverse pathologies, including infections and post-transplant inflammatory bowel disease (IBD). Immunosuppressants, crucial for preventing rejection, pose risks such as nausea, diarrhea, peptic ulcers, infections, and cancers. Diagnosing post-transplant colitis is challenging due to similar clinical and histological features. Pathologies include drug-induced colitis, infection-related colitis, graft-versus-host disease (GVHD), de novo IBD, neoplasms, post-transplant lymphoproliferative diseases (PTLD), and non-specific colitis. Each requires specific treatments, highlighting the need for a multidisciplinary approach. This study evaluates these lesions in our tertiary care center.
Methods: A retrospective study analyzed 46 post-renal and liver transplant patients who underwent GI endoscopy/colonoscopy biopsies at VPS Lakeshore, Kochi, between January 2017 and December 2022. Variables such as patient age, gender, presenting complaint, time from transplantation to symptoms, and histopathological diagnosis were analyzed using SPSS software.
Results: From 2017 to 2022, 46 out of 985 transplant recipients underwent GI biopsies (39 kidney, 7 liver). The cohort was predominantly male (93.5%) with a mean age of 54.93 years. Diarrhea was the primary symptom (45.7%), followed by dyspepsia and anemia, occurring on average 23 months post-transplant. Pathological findings included infection-related colitis (26.1%), drug-induced colitis (8.7%), de novo IBD (2.2%), neoplasms (2.2%), post-transplant lymphoproliferative diseases (2.2%), non-specific colitis (32.6%), and no significant pathology (26.1%).
Conclusion: Post-transplant gastrointestinal diseases are complex, impacting the health and quality of life of recipients. Timely diagnosis and personalized management are crucial. A multidisciplinary approach is essential for effective care, and continued research and clinical efforts are vital for improving outcomes.
References
Pittman ME, Jessurun J, Yantiss RK. Differentiating posttransplant inflammatory bowel disease and other colitides in renal transplant patients. Am J Surg Pathol. 2017;41(12):1666-74.
de Andrade LG, Rodrigues MA, Romeiro FG, Garcia PD, Contti MM, de Carvalho MF. Clinicopathologic features and outcome of mycophenolate-induced colitis in renal transplant recipients. Clin Transplant. 2014;28:1244-8.
Gioco R, Corona D, Ekser B, Puzzo L, Inserra G, Pinto F, et al. Gastrointestinal complications after kidney transplantation. World J Gastroenterol. 2020;26(38):5797-811.
Wong NA. Gastrointestinal pathology in transplant patients. Histopathology. 2015;66:467-79.
Bamias G, Boletis J, Argyropoulos T, Skalioti C, Siakavellas SI, Delladetsima I, et al. Early ileocolonoscopy with biopsy for the evaluation of persistent post-transplantation diarrhea. World J Gastroenterol. 2010;16(30):3834-40.
Gioco R, Puzzo L, Patanè M, Corona D, Trama G, Veroux P, et al. Post-transplant colitis after kidney transplantation: clinical, endoscopic and histological features. Aging (Albany NY). 2020;12(24):24709-20.
Lin SH, Wu KT, Wang CC, Liu TT, Eng HL, Chiu KW. Immunohistochemistry staining-proven cytomegalovirus colitis in living donor liver transplantation. Viruses. 2022;15(1):115.
Nepal S, Navaneethan U, Bennett AE, Shen B. De novo inflammatory bowel disease and its mimics after organ transplantation. Inflamm Bowel Dis. 2013;19(7):1518-27.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Merin Jaison, Pushpa Mahadevan, Resha Menon
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
